H.R. 1266 · 119th Congress

Combating Illicit Xylazine Act

Introduced on Feb 12, 2025 by Jimmy Panetta (D-CA-19). 114 cosponsors, 63 of them from another party. Latest action (Sep 16, 2026): Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.

Stage
Passed one chamber
Introduced
Feb 12, 2025
Cosponsors
114
63 from the other party
Policy area
Crime and Law Enforcement
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To prohibit certain uses of xylazine, and for other purposes.

Subjects

  • Congressional oversight
  • Consumer affairs
  • Criminal procedure and sentencing
  • Drug safety, medical device, and laboratory regulation
  • Drug trafficking and controlled substances
  • Licensing and registrations
  • Manufacturing
  • U.S. Sentencing Commission
  • Veterinary medicine and animal diseases

Summary

By the Congressional Research Service (Introduced in House, Feb 12, 2025). Public domain.

Combating Illicit Xylazine Act

This bill regulates xylazine under the Controlled Substances Act (CSA).

Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.

This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.

Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.

The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.

The bill also exempts xylazine manufacturers from the CSA's physical security requirements.

Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Jimmy PanettaD-CA-19Sponsor

Democrats · 51

Republicans · 63

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Feb 12, 2025Introduced in House
  2. Feb 12, 2025Introduced in House
  3. Feb 12, 2025 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Feb 12, 2025 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Feb 12, 2025 · HouseReferred to the Subcommittee on Health.
  6. Jun 25, 2026 · HouseSubcommittee Consideration and Mark-up Session Held
  7. Jun 25, 2026 · HouseForwarded by Subcommittee to Full Committee by Voice Vote.
  8. Jul 20, 2026 · HouseCommittee Consideration and Mark-up Session Held
  9. Jul 21, 2026 · HouseCommittee Consideration and Mark-up Session Held
  10. Jul 21, 2026 · HouseOrdered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.
  11. Sep 14, 2026Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
  12. Sep 14, 2026 · HouseReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.
  13. Sep 14, 2026Committee on the Judiciary discharged.
  14. Sep 14, 2026 · HouseCommittee on the Judiciary discharged.
  15. Sep 14, 2026 · HousePlaced on the Union Calendar, Calendar No. 715.
  16. Sep 15, 2026 · HouseMr. Guthrie moved to suspend the rules and pass the bill, as amended.
  17. Sep 15, 2026 · HouseConsidered under suspension of the rules. (consideration: CR H5671-5673)
  18. Sep 15, 2026 · HouseDEBATE - The House proceeded with forty minutes of debate on H.R. 1266.
  19. Sep 15, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
  20. Sep 15, 2026 · HouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5671-5672)
  21. Sep 15, 2026 · HouseMotion to reconsider laid on the table Agreed to without objection.
  22. Sep 16, 2026 · SenateReceived in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 623.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. AMERICAN VETERINARY MEDICAL ASSOCIATION6 reports
    $1.1M reported (all issues)
  2. DUE PROCESS INSTITUTE6 reports
    $160K reported (all issues)
  3. National Fraternal Order of Police6 reports
    $600K reported (all issues)
  4. Peace Officers Research Association of California6 reports
    $300K reported (all issues)
  5. American Civil Liberties Union2 reports
    $1.4M reported (all issues)
  6. DRUG POLICY ALLIANCE2 reports
    $18.6K reported (all issues)
  7. National Association of Criminal Defense Lawyers (NACDL)2 reports
    $30K reported (all issues)
  8. Sergeants Benevolent Association of New York City2 reports
    $70K reported (all issues)
  9. The Sentencing Project2 reports
    $31.5K reported (all issues)
  10. American Medical Association1 report
    $5.1M reported (all issues)Federal contractor: AMERICAN MEDICAL ASSOCIATION$371K in contracts, FY2026AI match · 99%
  11. PENNSYLVANIA FARM BUREAU1 report
    $10K reported (all issues)
  12. Southeast Georgia Hospital System1 report
    $24K reported (all issues)
  13. UNIVERSITY OF WISCONSIN-MADISON1 report
    $100K reported (all issues)

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.